ArticleDrugs in R&D2017

The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro.

Ashraf Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.